Literature DB >> 27523619

A Design of Experiment approach to predict product and process parameters for a spray dried influenza vaccine.

Gaurav Kanojia1, Geert-Jan Willems2, Henderik W Frijlink3, Gideon F A Kersten4, Peter C Soema5, Jean-Pierre Amorij2.   

Abstract

Spray dried vaccine formulations might be an alternative to traditional lyophilized vaccines. Compared to lyophilization, spray drying is a fast and cheap process extensively used for drying biologicals. The current study provides an approach that utilizes Design of Experiments for spray drying process to stabilize whole inactivated influenza virus (WIV) vaccine. The approach included systematically screening and optimizing the spray drying process variables, determining the desired process parameters and predicting product quality parameters. The process parameters inlet air temperature, nozzle gas flow rate and feed flow rate and their effect on WIV vaccine powder characteristics such as particle size, residual moisture content (RMC) and powder yield were investigated. Vaccine powders with a broad range of physical characteristics (RMC 1.2-4.9%, particle size 2.4-8.5μm and powder yield 42-82%) were obtained. WIV showed no significant loss in antigenicity as revealed by hemagglutination test. Furthermore, descriptive models generated by DoE software could be used to determine and select (set) spray drying process parameter. This was used to generate a dried WIV powder with predefined (predicted) characteristics. Moreover, the spray dried vaccine powders retained their antigenic stability even after storage for 3 months at 60°C. The approach used here enabled the generation of a thermostable, antigenic WIV vaccine powder with desired physical characteristics that could be potentially used for pulmonary administration.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Nozzle gas flow rate; Process optimization; Process parameters; Quality by design; Spray drying

Mesh:

Substances:

Year:  2016        PMID: 27523619     DOI: 10.1016/j.ijpharm.2016.08.022

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

1.  Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9.

Authors:  Nitesh K Kunda; Julianne Peabody; Lukai Zhai; Dominique N Price; Bryce Chackerian; Ebenezer Tumban; Pavan Muttil
Journal:  Hum Vaccin Immunother       Date:  2019-04-19       Impact factor: 3.452

2.  Spray-Dried Thiolated Chitosan-Coated Sodium Alginate Multilayer Microparticles for Vaginal HIV Microbicide Delivery.

Authors:  Jianing Meng; Vivek Agrahari; Miezan J Ezoulin; Sudhaunshu S Purohit; Tao Zhang; Agostino Molteni; Daniel Dim; Nathan A Oyler; Bi-Botti C Youan
Journal:  AAPS J       Date:  2017-01-30       Impact factor: 4.009

3.  Optimization of Spray-Drying Parameters for Formulation Development at Preclinical Scale.

Authors:  Marika Nespi; Robert Kuhn; Chun-Wan Yen; Joseph W Lubach; Dennis Leung
Journal:  AAPS PharmSciTech       Date:  2021-12-20       Impact factor: 3.246

4.  Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant.

Authors:  Kendall B Preston; Teri Ann S Wong; Albert To; Taylor E Tashiro; Michael M Lieberman; Alex Granados; Karen Feliciano; John Harrison; Jake Yalley-Ogunro; Hanne Andersen Elyard; Oreola Donini; Axel T Lehrer; Theodore W Randolph
Journal:  Vaccine       Date:  2021-08-13       Impact factor: 4.169

5.  Development of a formulation platform for a spray-dried, inhalable tuberculosis vaccine candidate.

Authors:  Mellissa Gomez; Joseph McCollum; Hui Wang; Mani Ordoubadi; Chester Jar; Nicholas B Carrigy; David Barona; Isobel Tetreau; Michelle Archer; Alana Gerhardt; Chris Press; Christopher B Fox; Ryan M Kramer; Reinhard Vehring
Journal:  Int J Pharm       Date:  2020-12-02       Impact factor: 5.875

6.  Microparticle encapsulation of a tuberculosis subunit vaccine candidate containing a nanoemulsion adjuvant via spray drying.

Authors:  Mellissa Gomez; Michelle Archer; David Barona; Hui Wang; Mani Ordoubadi; Shabab Bin Karim; Nicholas B Carrigy; Zheng Wang; Joseph McCollum; Chris Press; Alana Gerhardt; Christopher B Fox; Ryan M Kramer; Reinhard Vehring
Journal:  Eur J Pharm Biopharm       Date:  2021-03-19       Impact factor: 5.589

Review 7.  Developments in the formulation and delivery of spray dried vaccines.

Authors:  Gaurav Kanojia; Rimko Ten Have; Peter C Soema; Henderik Frijlink; Jean-Pierre Amorij; Gideon Kersten
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

8.  Improved Understanding of the High Shear Wet Granulation Process under the Paradigm of Quality by Design Using Salvia miltiorrhiza Granules.

Authors:  Yi Zhang; Brian Chi-Yan Cheng; Wenjuan Zhou; Bing Xu; Xiaoyan Gao; Yanjiang Qiao; Gan Luo
Journal:  Pharmaceutics       Date:  2019-10-09       Impact factor: 6.321

9.  Peptide Isolation via Spray Drying: Particle Formation, Process Design and Implementation for the Production of Spray Dried Glucagon.

Authors:  Frederik J S Doerr; Lee J Burns; Becky Lee; Jeremy Hinds; Rebecca L Davis-Harrison; Scott A Frank; Alastair J Florence
Journal:  Pharm Res       Date:  2020-12-14       Impact factor: 4.200

10.  Rational Design of a Glycoconjugate Vaccine against Group A Streptococcus.

Authors:  Roberta Di Benedetto; Francesca Mancini; Martina Carducci; Gianmarco Gasperini; Danilo Gomes Moriel; Allan Saul; Francesca Necchi; Rino Rappuoli; Francesca Micoli
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.